Detalhe da pesquisa
1.
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.
J Antimicrob Chemother
; 71(3): 821-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26679243
2.
A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization.
Antimicrob Agents Chemother
; 59(6): 3469-73, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845864
3.
The Pharmacokinetics of the CYP3A Substrate Midazolam After Steady-state Dosing of Delafloxacin.
Clin Ther
; 39(6): 1182-1190, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495029
4.
Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.
J Clin Pharmacol
; 57(3): 328-335, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27570245
5.
Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations.
Antimicrob Agents Chemother
; 46(1): 191-5, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11751133